HDAC5 modulates SATB1 transcriptional activity to promote lung adenocarcinoma

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Background:

• Histone deacetylases (HDACs) dysregulation is implicated in various cancers.
• HDAC5, a Class IIa histone deacetylase, has a limited known substrate repertoire, hindering understanding of its role in tumorigenesis.

Purpose of the Study:

• To identify and characterize novel HDAC5 interacting proteins and substrates.
• To elucidate the molecular mechanisms by which HDAC5 contributes to tumorigenesis through its interaction with SATB1.

Main Methods:

• Biochemical screening to identify HDAC5-interacting proteins.
• Coimmunoprecipitation and deacetylation assays to validate SATB1 as a HDAC5 substrate.
• In vitro and in vivo assays (proliferation, migration, xenografts) to assess the functional impact of the HDAC5-SATB1 interaction on tumor progression.

Main Results:

• SATB1 was identified as a direct binding partner and substrate of HDAC5, deacetylated at lysine 411.
• HDAC5-mediated deacetylation of SATB1 is essential for the downregulation of key tumor suppressor genes.
• Deacetylated SATB1 inhibits SDHA-induced epigenetic remodeling and anti-proliferative transcriptional programs, promoting a malignant phenotype.

Conclusions:

• HDAC5 plays a critical role in tumorigenesis by regulating SATB1.
• The findings provide novel insights into the molecular mechanisms driving SATB1-mediated tumor growth and metastasis.